Suchergebnisse - "1757-6199" OR "1757-6180"

PubPharm (79)

71

Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond

enthalten in: Bioanalysis | 2020

von Kar, S. | Islam, R.

72

Exhaled breath condensate as a potential specimen for diagnosing COVID-19

enthalten in: Bioanalysis | 2020

von Khoubnasabjafari, M. | Jouyban-Gharamaleki, V. | Ghanbari, R. | +1

73

How ADA methodology informs SARS-CoV-2 assay development

enthalten in: Bioanalysis | 2020

von Becker, C.

74

Safety considerations in the bioanalytical laboratories handling specimens from coronavirus disease 2019 patients

enthalten in: Bioanalysis | 2020

von Chen, Z. | Sikorski, T.

75

Point-of-care and utility in clinical trials : making quicker decisions to transform patient care and drug development

enthalten in: Bioanalysis | 2020

von Fischer, S.

76

Evaluation of a novel blood microsampling device for clinical trial sample collection and protein biomarker analysis

enthalten in: Bioanalysis | 2020

von Xing, J. | Loureiro, J. | Patel, M. | +2

77

Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays

enthalten in: Bioanalysis | 2020

von Zava, T. | Zava, D.

78

China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval

enthalten in: Bioanalysis | 2020

von Lv, Y. | He, J. | Liu, R. | +9

79

Could breath analysis by MS could be a solution to rapid, non-invasive testing for COVID-19?

enthalten in: Bioanalysis | 2020

von Walker, H. | Burrell, M.

[1]
« Vorheriger
1
2
3
4
5
6
7
8